![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 471/04 | (2006.01) |
C07F 9/60 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61K 31/5025 | (2006.01) |
(11) | Number of the document | 3704118 |
(13) | Kind of document | T |
(96) | European patent application number | 18804177.6 |
Date of filing the European patent application | 2018-10-29 | |
(97) | Date of publication of the European application | 2020-09-09 |
(45) | Date of publication and mention of the grant of the patent | 2022-01-12 |
(46) | Date of publication of the claims translation | 2022-02-25 |
(86) | Number | PCT/US2018/057968 |
Date | 2018-10-29 |
(87) | Number | WO 2019/089442 |
Date | 2019-05-09 |
(30) | Number | Date | Country code |
201762578607 P | 2017-10-30 | US | |
201862626853 P | 2018-02-06 | US |
(72) |
MERTZMAN, Michael E. , US
DZIERBA, Carolyn Diane , US
GUERNON, Jason M. , US
HART, Amy C. , US
LUO, Guanglin , US
MACOR, John E. , US
PITTS, William J. , US
SHI, Jianliang , US
SPERGEL, Steven H. , US
|
(73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Aminoimidazopiridazinai, kaip kinazės inhibitoriai |
AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS |
Payment date | Validity (years) | Amount | |
2022-10-24 | 5 | 115.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2023-10-29 |